Groowe Groowe / Newsroom / NVAX
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

NVAX News

Novavax Inc

Novavax to Participate in 2026 Jefferies Global Healthcare Conference

prnewswire.com
NVAX

$94 Bn Vaccines Market Industry Trends and Global Forecasts, 2026-2035: 200+ Preventive Vaccines, Developed by Both Industry and Non-industry Players are Being Evaluated

globenewswire.com
EBS NVAX MRNA PFE

Novavax to Participate in BofA Securities 2026 Health Care Conference

prnewswire.com
NVAX

Form 8-K

sec.gov
NVAX

Novavax Reports First Quarter 2026 Financial Results and Operational Highlights

prnewswire.com
NVAX

DELFI Diagnostics Appoints Charles Newton to Board of Directors

prnewswire.com
NVAX CHRS

Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development

prnewswire.com
NVAX

NAYA Therapeutics Announces World-Class Board of Directors

accessnewswire.com
AMGN NVAX MRK CDXS ABBV ALGS

Nuvaxovid (Novavax) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

globenewswire.com
NVAX

Form 8-K

sec.gov
NVAX